Polymyxin-class Antibacterial [EPC]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Polymyxin-class Antibacterial [EPC] includes 2 drugs with a combined 1,489 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
1,489
Combined Reports
All Polymyxin-class Antibacterial [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| COLISTIMETHATE | Colistimethate | 845 | 142 | 348 | 16.8% |
| POLYMYXIN B | polymyxin b sulfate and trimethoprim sulfate | 644 | 114 | 200 | 17.7% |
Common Side Effects in Polymyxin-class Antibacterial [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Drug ineffective | 308 | 58 |
| Off label use | 181 | 20 |
| Macular degeneration | 168 | 0 |
| Acute kidney injury | 144 | 18 |
| Condition aggravated | 88 | 14 |
| Drug hypersensitivity | 72 | 2 |
| Nausea | 69 | 1 |
| Pain | 66 | 0 |
| Malaise | 57 | 2 |
| Death | 55 | 54 |